NCT02242695

Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis

Comparative Study of the Efficacy of 10.0 mg Dequalinium Chloride (Fluomizin®) and 100 mg Clotrimazole (Canesten®) for the Treatment of Vulvovaginal Candidiasis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 150 (actual)
• Sponsor: Medinova AG · Industry
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

A clinical study to compare the clinical efficacy of vaginal tablets containing 10mg dequalinium chloride (Fluomizin) with the clinical efficacy of 100mg clotrimazole in patients suffering from vulvovaginal candidiasis, to assess safety of the two medications during the treatment, and to evaluate women's satisfaction with the two treatments.

Conditions

• Vulvovaginal Candidiasis

Interventions

Type	Name	Description
DRUG	Fluomizin vaginal tablets	One vaginal tablet for 6 days and 1 placebo tablet on day 7
DRUG	Canesten vaginal tablets	one vaginal tablet for 7 days

Timeline

• Start date: 2014-11-01
• Primary completion: 2015-12-01
• Completion: 2016-04-01
• First posted: 2014-09-17
• Last updated: 2016-09-15

Locations

1 site across 1 country: Thailand